Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine [0.03%]
新型迷幻疗法在创伤后应激障碍治疗中的应用及其精准医疗前景
Charles Dodds,Rachelle Dawson,Alexander Lim et al.
Charles Dodds et al.
Novel interventions for post-traumatic stress disorder (PTSD) leverage the psychoactive properties of psychedelic compounds, such as ketamine, 3,4-methylenedioxymethamphetamine and psilocybin, which may overcome limitations of conventional ...
Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis [0.03%]
评论：致幻剂治疗对精神疾病诊断患者的自杀意念、企图和死亡的影响：系统评价和meta分析
Tiago Machado,Alexandra S L Rodrigues,João Costa
Tiago Machado
Jim van Schie,Peter Lucassen,Tom Birkenhäger et al.
Jim van Schie et al.
Background: Many antidepressant users experience the process of stopping as challenging because of withdrawal symptoms. Support factors, such as patients experiencing empathy from their healthcare providers, potentially c...
Aleksander Kwaśny,Wiesław Jerzy Cubała,Alina Wilkowska
Aleksander Kwaśny
Background: Intravenous ketamine is effective in treatment-resistant bipolar depression (TRBD) with dosing typically based on actual body weight (ABW). Ob...
The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences [0.03%]
受控辅助治疗中疗愈性触摸的伦理使用：研究人员视角与体验的质性研究
Diana McHerron,Michaela Barber,Rachel Ham et al.
Diana McHerron et al.
Background: Physical touch is often included as a supportive or therapeutic tool in psychedelic-assisted therapy (PAT), involving instrumental forms of physical contact, supportive touch and somatic techniques. However, p...
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis [0.03%]
氯胺酮与艾司氯胺酮治疗抑郁的系统评价和meta分析
Ahmed Elmosalamy,Idil Tarikogullari,Liliana Patarroyo-Rodriguez et al.
Ahmed Elmosalamy et al.
Background: Depression affects approximately 5.7% of adults worldwide, and around one-third of these individuals develop treatment-resistant depression (TRD). Intravenous (IV) ketamine and esketamine (administered IV or i...
Corrigendum to "Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design" [0.03%]
对“迷幻辅助疗法作为复杂干预措施：临床试验设计的影响”的勘误通知
[This corrects the article DOI: 10.1177/20451253251381074.]. © The Author(s), 2025.
Psychotropic medications adherence status and its determinants among older adults with severe affective and psychotic disorders: a multicenter cross-sectional study [0.03%]
老年严重心境障碍和精神病患者精神药物依从性及其影响因素的多中心横断面研究
Woretaw Sisay Zewdu,Tigabu Eskeziya Zerihun,Desalegn Addis Mussie et al.
Woretaw Sisay Zewdu et al.
Background: Nonadherence jeopardizes treatment outcomes in the psychiatric care continuum. However, there was a paucity of data in the resource-limited life trajectories. ...
Oral contraceptive formulation and socio-cognitive performance: a short communication [0.03%]
口服避孕药的配方与社会认知表现：简短通讯
Minhal Mussawar,Sneha Chenji,Christine Bueno et al.
Minhal Mussawar et al.
Background: Oral contraceptives (OC) offer a range of ethinyl estradiol (EE) doses and progestin types, with evidence indicating marked differences in cognitive and emotional abilities in OC users. However, it remains unc...
Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysis [0.03%]
与接受丙戊酸钠治疗的精神疾病住院患者高血氨症相关的临床和生化因素：横断面分析
Ilaria Riboldi,Daniele Cavaleri,Marco Morreale et al.
Ilaria Riboldi et al.
Background: Valproic acid (VPA)-induced hyperammonemia is a common condition whose clinical presentations can range from asymptomatic cases to severe hyperammonemic encephalopathy. This can happen at any stage of treatmen...